Skip navigation

Calls to Action

Today's IACC Webcast Features Autism Speaks ATN Experts on Associated Medical Conditions

September 19, 2014

(Sept. 23, 2014) Today the federal Interagency Autism Coordinating Committee (IACC) has invited a roster of Autism Speaks Autism Treatment Network (ATN) specialists and Autism-Speaks funded researchers to update the committee and the public at a special workshop on “Under-recognized Co-occurring Conditions in Autism Spectrum Disorder.” 

The public is invited to attend in person or by live webcast or conference call. For information, consult the workshop’s IACC webpage

Autism Speaks ATN clinicians and funded researchers are highlighted throughout the workshop agenda below.

IACC Workshop: Under-recognized Co-occurring Conditions in Autism Spectrum Disorder


Topic and Speaker


**Autism Speaks Autism Treatment Network physician
++Autism Speaks-funded researcher

  9:00 a.m.

Welcome and Introductions

Thomas Insel, M.D.
Director, National Institute of Mental Health (NIMH)
Chair, IACC

Geraldine Dawson, Ph.D., F.A.P.A., F.A.P.S.
Director, Duke Center for Autism and Brain Development
Duke University School of Medicine
Co-Chair, IACC Basic and Translational Research Subcommittee

Susan Daniels, Ph.D.
Director, Office of Autism Research Coordination (OARC), NIMH
Executive Secretary, IACC


Panel 1: Overview of Co-Occurring Conditions in Children and Adults – What have We Learned about Co-Occurring Conditions from Epidemiological and Clinical Experience?

Anjali Jain, M.D.
Vice President Lewin Group

Lisa Croen, Ph.D., M.P.H. ++
Director, Kaiser Permanente Autism Research Program

Isaac Kohane, M.D., Ph.D.
Professor of Pediatrics and Health Sciences and Technology
Harvard  Medical School

Daniel L. Coury, M.D. **
Medical Director, Autism Speaks Autism Treatment Network
Chief, Developmental and Behavioral Pediatrics & Child Development Center, Nationwide Children's Hospital
Professor of Pediatrics and Psychiatry, College of Medicine, Ohio State University






Panel 2: Psychiatric Disorders

Lawrence Scahill, Ph.D., M.S.N., M.P.H.
Professor of Psychiatry, School of Medicine
Director of Clinical Trials, Marcus Autism Center
Emory University

Jeffrey Wood, Ph.D. ** ++
Clinical Child Psychologist Associate Professor
Division of Child Psychiatry and Human Development and Psychology
University of California, Los Angeles

Evdokia Anagnostou, M.D.** ++
Senior Clinician Scientist,
Bloorview Research Institute, University of Toronto
Canada Research Chair in Translational therapeutics in ASD
University of Toronto



 12:15 p.m.



Public Comment


Discussion of Public Comment


Panel 3: Sleep and Neurological Disorders

Beth Malow, M.D., M.S.** ++
Professor of Neurology and Pediatrics
School of Medicine Vanderbilt University

Ashura Buckley, M.D.
Clinical Investigator, National Institute of Mental Health

Mustafa Sahin, M.D., Ph.D.++
Director of Translational Neuroscience Center, Boston Children's Hospital
Associate Professor of Neurology Harvard Medical School






Panel 4: Metabolic and Immune Disorders

Carlos Pardo-Villamizar, M.D.
Associate Professor of Neurology and Pathology
School of Medicine Johns Hopkins University

Judy Van de Water, Ph.D. ++
Director, Center for Children's Environmental Health
MIND Institute University of California, Davis

Robert K. Naviaux, M.D., Ph.D., M.S. ++
Co-Director, Mitochondrial and Metabolic Disease Center
School of Medicine University of California, San Diego



Learn more about the Autism Speaks Autism Treatment Network here.

Find the ATN center nearest you here.

Explore the research projects Autism Speaks is funding here